Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Breast Cancer Breast Cancer for January/February 2021 U.S. mothers underestimate role breastfeeding plays in curbing breast cancer, More must reads Breast Cancer for November/December 2020 Study: Doctors underreport side effects of breast irradiation, No edge for anastrozole over tamoxifen in DCIS, Long-term APBI cosmetic, toxicity data reported WBI has the edge Practice-confirming results, Omitting postop radiotherapy doesn’t affect survival in older breast cancer patients, An all-oral option for advanced HR+, HER2– breast cancer?, More must readsBreast Cancer for September/October 2020 ‘Tour de force’ study reveals therapeutic targets in 38% of cancer patients, Pathologic CR in HER2+ breast cancer predicts long-term survival, Combined features of benign breast disease tied to breast cancer risk, Gene signature found similarly prognostic in ILC and IDC, Study advances personalized treatment for older breast cancer patients, More must readsBreast Cancer for July/August 2020 VTE, sepsis risk increased among COVID-19 patients with cancer, Aspirin may accelerate cancer progression in older adults, Beyond baseline, DBT no better than mammography for dense breasts, System provides ‘faster, less invasive’ method for breast cancer detection, Higher death rate seen in cancer patients with nosocomial COVID-19, More must readsBreast Cancer for May/June 2020 Novel SERD, LSZ102, shows promise for pretreated ER+ breast cancer, Personalized cancer vaccine may enhance checkpoint inhibitor activity, Beta-blocker use not linked to improved breast cancer prognosis, DCIS diagnosis tied to increased risk of breast cancer, Palbociclib-letrozole is safe, effective in Japanese patients with advanced breast cancer, More must readsPages1 2 3 4 5 6 7 last »
